Clinical trials
Ovarian Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
347 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 7 |
| 2014 | 2 |
| 2015 | 11 |
| 2016 | 6 |
| 2017 | 16 |
| 2018 | 16 |
| 2019 | 15 |
| 2020 | 21 |
| 2021 | 40 |
| 2022 | 44 |
| 2023 | 34 |
| 2024 | 43 |
| 2025 | 46 |
| 2026 | 35 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 113 |
| Unknown status | 110 |
| Completed | 54 |
| Active, not recruiting | 27 |
| Not yet recruiting | 26 |
| Terminated | 13 |
| Suspended | 2 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 13 |
| Tongji Hospital | 12 |
| Fudan University | 10 |
| Jiangsu HengRui Medicine Co., Ltd. | 10 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 10 |
| Shanghai Gynecologic Oncology Group | 9 |
| Sun Yat-sen University | 9 |
| Peking Union Medical College Hospital | 8 |
| Lei Li | 7 |
| Chinese PLA General Hospital | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 347 |
| Breast Neoplasms | 50 |
| Uterine Cervical Neoplasms | 48 |
| Endometrial Neoplasms | 41 |
| Fallopian Tube Neoplasms | 39 |
| Pancreatic Neoplasms | 31 |
| Colorectal Neoplasms | 29 |
| Lung Neoplasms | 28 |
| Stomach Neoplasms | 25 |
| Carcinoma, Ovarian Epithelial | 23 |
Trials
Showing 76 to 100 of 347. Each trial links to its page on Pharma Observatory.
247 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.